MedTrace Logo

Usability Evaluation of the Intelligent Fingerprinting Drug Screening System

NCT07758777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-08-11

No results posted yet for this study

Summary

This is a prospective performance evaluation of usability of the Intelligent Fingerprinting Drug Screening System, conducted in clinic. The total number of healthy adult subjects (male and female) required for enrollment in this study protocol is 45: 15 operators and 30 donors (ideally two donors assigned to one operator). The total duration of the study, from check-in through the end of the study will be 2-4 hours for each donor subject.

Conditions

  • Healthy Adult Participants

Interventions

DIAGNOSTIC_TEST

Diagnostic procedures

Training in the use of the Intelligent Fingerprinting Drug Screening System.

DEVICE

Drug Screening

Screening for drug use

Sponsors & Collaborators

  • Intelligent Bio Solutions Inc.

    lead INDUSTRY

Principal Investigators

  • Elan Cohen, PhD · CenExel HRI

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-20
Primary Completion
2026-07-24
Completion
2026-07-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07758777 on ClinicalTrials.gov